Gut Liver.  2018 Jan;12(1):7-16. 10.5009/gnl16615.

Current Trends in the Management of Gastroesophageal Reflux Disease

Affiliations
  • 1The Esophageal and Swallowing Center, Division of Gastroenterology and Hepatology, MetroHealth Medical Center, Case Western Reserve University, Cleveland, OH, USA. ronnie.fass@gmail.com

Abstract

Gastroesophageal reflux disease (GERD) characterized by heartburn and/or regurgitation symptoms is one of the most common gastrointestinal disorders managed by gastroenterologists and primary care physicians. There has been an increase in GERD prevalence, particularly in North America and East Asia. Over the past three decades proton pump inhibitors (PPIs) have been the mainstay of medical therapy for GERD. However, recently there has been an increasing awareness amongst physicians and patients regarding the side effects of the PPI class of drugs. In addition, there has been a marked decline in the utilization of surgical fundoplication as well as a rise in the development of nonmedical therapeutic modalities for GERD. This review focuses on different management strategies for GERD, optimal management of refractory GERD with special focus on available endoluminal therapies and the future directions.

Keyword

Gastroesophageal reflux; Proton pump inhibitors; Heartburn; Surgery

MeSH Terms

Far East
Fundoplication
Gastroesophageal Reflux*
Heartburn
Humans
North America
Physicians, Primary Care
Prevalence
Proton Pump Inhibitors
Proton Pump Inhibitors
Full Text Links
  • GNL
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
    DB Error: unknown error